Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria:
1. Age ≥18 years
2. Patients that need a treatment with a BioMatrix™ drug-eluting stent
3. Presence of one or more coronary artery stenoses in a native coronary artery or a
saphenous bypass graft from 2.25 to 4.0 mm in diameter that can be covered with one
or multiple stents
4. No limitation on the number of treated lesions, and vessels, and lesion length
Exclusion Criteria:
1. Inability to provide informed consent
2. Patients needing additional stent NOT of the BioMatrix™ type
3. Patients receiving next to the BioMatrix™ stent also other coronary vascular
interventions, for example dilation.

Additional Information

Official title

A Postmarket Surveillance Registry of the BioMatrix Drug-eluting Stent

Principal investigator

Philip Urban, MD

Trial information was received from ClinicalTrials.gov and was last updated in September 2014.